Cargando…
Bone age is the best predictor of growth response to recombinant human growth hormone in Turner’s syndrome
BACKGROUND AND OBJECTIVES: Recombinant human growth hormone (rhGH) is approved for use in children with Turner’s syndrome (TS) in most industrialized countries and is recommended in the recently issued guidelines. We determined the growth responses of girls who are treated with rhGH for TS, with an...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009421/ https://www.ncbi.nlm.nih.gov/pubmed/21206698 http://dx.doi.org/10.4103/0971-6866.73400 |